Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Morie A Gertz

1-50 of 846 results

International uniform response criteria for multiple myeloma.

scientific article

Improved survival in multiple myeloma and the impact of novel therapies

scientific article

Review of 1027 patients with newly diagnosed multiple myeloma

scientific article

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

scientific article published on 25 October 2013

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

scientific article

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

scientific article published on 23 August 2005

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

scientific article published in September 2004

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

scientific article

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

scientific article published on 22 October 2012

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

scientific article

POEMS syndrome: definitions and long-term outcome

scientific article

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

scientific article published in November 2002

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

scientific article published on 13 February 2012

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

scientific article

Amyloidosis: pathogenesis and new therapeutic options.

scientific article

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

scientific article

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

scientific article published on 03 February 2011

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

scientific article published in February 2010

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

scientific article published on 21 June 2007

Remission of disseminated cancer after systemic oncolytic virotherapy

scientific article

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

scientific article published on 23 June 2005

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

scientific article published on 01 April 1997

Clinical course of patients with relapsed multiple myeloma

scientific article published in July 2004

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Genetic aberrations and survival in plasma cell leukemia

scientific article published on 24 January 2008

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989

scientific article published on April 1, 1992

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

article

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

scientific article

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 25 March 2004

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

scientific article published on 05 April 2012

Doppler characterization of left ventricular diastolic function in cardiac amyloidosis

scientific article published in April 1989

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

scientific article published on 01 August 2001

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

scientific article published on February 2009

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

scientific article published on 20 June 2011

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

Autologous stem cell transplantation for primary systemic amyloidosis

scientific article

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

scientific article published on 10 January 2012

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

scientific article published on 01 July 2018

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

scientific article

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction

scientific article

Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).

scientific article

Thalidomide as initial therapy for early-stage myeloma

scientific article published in April 2003

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

scientific article published on August 2006

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

scientific article published on 18 January 2007

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma

scientific article published on 16 June 2005

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

scientific article

Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia

scientific article published on December 2008

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

scientific article published on 01 February 2003

Genomic abnormalities in monoclonal gammopathy of undetermined significance

scientific article published on 01 August 2002